FOXO3 and breast cancer: Hsa_circ_0025202 levels are decreased in breast cancer vs. control samples, and overexpression of hsa_circ_0025202 could enhance breast cancer tamoxifen sensitivity by modulating miR-182-5p/FOXO3a signaling [63].